Overall Results and Quarterly Trends

As of 24 January 2026, a total of 409 companies have declared their December 2025 quarter results. The proportion of companies reporting positive earnings has risen steadily over the last four quarters, from 40.0% in June 2025 to 54.0% in December 2025. This upward trend suggests improving corporate profitability and resilience despite ongoing macroeconomic challenges.

However, the distribution of positive results varies significantly by market capitalisation. Large-cap companies have reported a relatively modest 37.0% positive results, indicating some pressure on the blue-chip segment. In contrast, mid-cap companies have delivered a robust 61.0% positive result ratio, while small caps have also outperformed large caps with 56.0% positive results. This divergence highlights a rotation of earnings strength towards mid and small-cap segments.

Sectoral and Market Cap Highlights

Among large caps, Piramal Finance has been a top performer, although detailed sectoral data remains limited. Mid-cap stocks have been led by Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, which has demonstrated exceptional financial metrics for the quarter. Small caps have seen Indo Thai Securities, operating in the Capital Markets sector, deliver strong results, while micro caps such as String Metaverse (Paper, Forest & Jute Products) and Sera Investments (NBFC) have also stood out.

Exceptional Performance by Laurus Labs

Laurus Labs Ltd., with a market capitalisation of ₹54,911.51 crores, has reported an outstanding quarter ending December 2025. The company’s profit before tax (excluding other income) surged by 164.6% to ₹320.80 crores, while net profit after tax soared by 172.7% to ₹251.66 crores. Net sales increased by 25.7% to ₹1,778.29 crores, marking the highest quarterly sales in the company’s history.

Operating profit to interest ratio reached an impressive 12.38 times, reflecting strong operational efficiency and manageable debt levels. The operating profit margin stood at 27.0%, with PBDIT hitting a record ₹480.21 crores. Laurus Labs’ earnings per share (EPS) rose to ₹4.66, the highest recorded for the company, while the debt-to-equity ratio improved to a low 0.46 times as of the half-year mark. These metrics underscore Laurus Labs’ robust financial health and growth trajectory.

Mid and Small Caps Driving Earnings Momentum

The mid-cap segment’s strong showing is further exemplified by the Pharmaceuticals & Biotechnology sector, where Laurus Labs’ stellar results have set a benchmark. This sector’s resilience is critical given the global demand for healthcare innovation and generic drug manufacturing. Meanwhile, small caps such as Indo Thai Securities have benefited from buoyant capital markets activity, reflecting increased investor participation and trading volumes.

Micro-cap companies like String Metaverse and Sera Investments have also contributed to the positive earnings narrative, with their niche sector focus in Paper, Forest & Jute Products and NBFCs respectively. These companies’ ability to deliver strong quarterly profits despite their smaller scale highlights the potential for selective stock picking in less covered market segments.

Large Cap Challenges and Outlook

Large-cap companies have faced headwinds, with only 37.0% reporting positive results. This subdued performance may be attributed to sectoral pressures, global economic uncertainties, and margin compression in certain industries. Investors should monitor upcoming results from major large caps such as Axis Bank Ltd., which is scheduled to report on 26 January 2026, and CG Power & Industrial Solutions Ltd. on 27 January 2026, for further clarity on the blue-chip earnings trajectory.

Despite these challenges, pockets of strength remain, as evidenced by Piramal Finance’s top-tier results. The financial services sector continues to be a key driver of market sentiment, with credit growth and asset quality trends closely watched by analysts.

Aggregate Profit Growth and Market Implications

The aggregate profit growth for the December 2025 quarter has been buoyed primarily by mid and small caps, signalling a shift in market leadership. The improvement from 43.0% positive results in September 2025 to 54.0% in December 2025 reflects a broadening recovery across sectors and market capitalisations. This trend may encourage investors to diversify beyond traditional large-cap holdings to capture growth opportunities in emerging segments.

However, the mixed results also warrant caution. The relatively low positive result ratio among large caps suggests that macroeconomic uncertainties and sector-specific challenges remain. Investors should balance exposure across market caps and sectors, focusing on companies with strong fundamentals, efficient capital structures, and sustainable earnings growth.

Upcoming Earnings to Watch

Market participants will closely watch the earnings announcements of Avantel Ltd on 25 January 2026, Axis Bank Ltd on 26 January 2026, and CG Power & Industrial Solutions Ltd on 27 January 2026. These results will provide further insights into sectoral trends and the sustainability of the current earnings momentum heading into the new calendar year.

Conclusion

The December 2025 quarterly earnings season has delivered a cautiously positive message, with mid and small caps leading the charge in profit growth. Laurus Labs’ exceptional performance in the Pharmaceuticals & Biotechnology sector exemplifies the potential for strong earnings growth in select industries. While large caps face ongoing challenges, the overall improvement in positive results signals a gradual recovery in corporate profitability. Investors are advised to adopt a discerning approach, focusing on quality companies with robust financial metrics and growth prospects as the market navigates evolving economic conditions.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →